Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.9396
+0.0012 (0.13%)
At close: May 14, 2025, 4:00 PM
0.9300
-0.0096 (-1.02%)
After-hours: May 14, 2025, 6:54 PM EDT
Iterum Therapeutics Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Iterum Therapeutics stock ranges from a low of $5.00 to a high of $9.00. The average analyst price target of $7.00 forecasts a 645.00% increase in the stock price over the next year.
Price Target: $7.00 (+645.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Iterum Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +857.85% | May 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +432.14% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +432.14% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +538.57% | Jun 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +538.57% | May 31, 2024 |
Financial Forecast
Revenue This Year
9.52M
Revenue Next Year
19.84M
from 9.52M
Increased by 108.39%
EPS This Year
-0.65
from -1.26
EPS Next Year
-0.52
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.8M | 20.4M | 43.1M | ||
| Avg | 9.5M | 19.8M | 41.9M | ||
| Low | 9.1M | 19.1M | 40.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 114.5% | 117.3% | ||
| Avg | - | 108.4% | 111.1% | ||
| Low | - | 100.2% | 102.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.67 | -0.54 | 0.07 |
| Avg | -0.65 | -0.52 | 0.07 |
| Low | -0.63 | -0.50 | 0.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.